What's New in Critical Illness and Injury Science? Mortality effects of tocilizumab for patients admitted with COVID-19 pneumonia
Int J Crit Illn Inj Sci
.
2021 Apr-Jun;11(2):49-50.
doi: 10.4103/ijciis.ijciis_52_21.
Epub 2021 Jun 29.
Authors
Andrew C Miller
1
,
Yannick A D'Silva
2
,
Eric A Gruber
1
Affiliations
1
Department of Emergency Medicine, Nazareth Hospital, Philadelphia, PA, USA.
2
Department of Internal Medicine, Nazareth Hospital, Philadelphia, PA, USA.
PMID:
34395203
PMCID:
PMC8318164
DOI:
10.4103/ijciis.ijciis_52_21
No abstract available
Publication types
Editorial